Translational Science 22 conference proceedings

Area of Science:

• Clinical and Translational Science
• Medical Research
• Scientific Conferences

Background:

• The Association of Clinical and Translational Science (ACTS) conference is a key event for sharing research.
• The TS22 conference in Chicago (April 2022) was the first in-person ACTS meeting since the COVID-19 pandemic began.
• A hybrid format was adopted to balance in-person interaction with virtual accessibility due to ongoing COVID-19 risks.

Purpose of the Study:

• To summarize key scientific advances presented at the TS22 conference.
• To provide an overview of three selected plenary sessions from the meeting.
• To capture the essence of the scientific discourse following the pandemic.

Main Methods:

• The study is a perspective piece summarizing plenary sessions.
• Junior Editors for the Journal of Clinical and Translational Science (JCTS) were invited to report on sessions.
• Content is derived from observations and reports of three specific plenary sessions.

Main Results:

• The conference successfully reconvened members of the ACTS for in-person scientific exchange.
• The hybrid format allowed for broader participation, accommodating both physical and virtual attendees.
• Key scientific advances were shared across various domains of clinical and translational science.

Conclusions:

• The TS22 conference demonstrated the resilience and adaptability of the clinical and translational science community.
• The event successfully facilitated the sharing of critical scientific updates in a hybrid format.
• The perspective highlights the importance of continued in-person and virtual collaboration in advancing science.